Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OLYMPE: High-Dose EC-MPS with Reduced Tacrolimus in Kidney Transplant
NCT00284934Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00284934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284934.